• Login
    View Item 
    •   ResearchSpace Home
    • College of Law and Management Studies
    • Graduate School of Business and Leadership
    • Masters Degrees (Graduate School of Business and Leadership)
    • View Item
    •   ResearchSpace Home
    • College of Law and Management Studies
    • Graduate School of Business and Leadership
    • Masters Degrees (Graduate School of Business and Leadership)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Should companies be incentivized for HIV/AIDS programs?

    Thumbnail
    View/Open
    Thesis (1023.Kb)
    Date
    2015
    Author
    Nxele, Sinempilo.
    Metadata
    Show full item record
    Abstract
    The HIV/AIDS epidemic impact is far beyond the household level. HIV/AIDS has affected companies and economies at large. The HIV/AIDS epidemic has an increasing effect on costs and a decreasing effect on productivity and ultimately a decrease in companies’ profits. The challenge facing companies is that they have to incur costs and spend on HIV/AIDS programs in order to decrease the impact on the company’s bottom line (i.e. Profit) and for the developmental progress and sustainability of the company and the economy. The objective of this study is to analyze the costs incurred by companies on HIV/AIDS and to assess whether companies should be incentivized for cost incurred through HIV/AIDS program. This was a retrospective study conducted in the Tongaat Huletts Company. The data used for the study was the Health and Safety summary reports of the company for the past five years. It was found that the number of employees with HIV/AIDS has increased by 21% from 2011 to the 2014 financial year. There has been a 7% increase in the VCT (Voluntary Counselling and Testing) uptake over the past 4 years and the company has spent R7, 746,971 on HIV/AIDS programs in the past 4 years. While the number of newly infected employees has increased by 21% over the last 4 years the staff turnover rate as a result of HIV/AIDS has not increased. This is possibly due to the increase in the number of employees on ARTs (Antiretroviral Therapy) and access to medication and staff welfare educational programs.
    URI
    http://hdl.handle.net/10413/14692
    Collections
    • Masters Degrees (Graduate School of Business and Leadership) [858]

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
    Theme by 
    @mire NV
     

     

    Browse

    All of ResearchSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsAdvisorsTypeThis CollectionBy Issue DateAuthorsTitlesSubjectsAdvisorsType

    My Account

    LoginRegister

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
    Theme by 
    @mire NV